Выберите регион

Подпишитесь на нашу новостную ленту

Подписаться

28.05.2026
Getinge’s subsidiary Maquet Cardiovascular receives adverse jury trial verdict in patent infringement dispute with Abiomed in the U.S.

Getinge today announces that a jury in the United States District Court for the District of Massachusetts has delivered a verdict in favor of Abiomed Inc (“Abiomed”) in a patent dispute between Getinge’s subsidiary Maquet Cardiovascular LLC (“Maquet”) and Abiomed. The jury found that Abiomed has not infringed any Maquet patents relating to intravascular heart pump technology.

21.04.2026
Resolutions at Getinge’s Annual General Meeting April 21, 2026

Getinge AB (publ)’s Annual General Meeting (“AGM”) was held on April 21, 2026 in Kongresshallen, Hotel Tylösand, Halmstad, Sweden. At the AGM, the following was resolved.

21.04.2026
Getinge Interim Report January-March 2026: Organic growth, strong cash flow and regulatory milestone

“We succeeded in surpassing last year’s record-breaking first quarter with organic growth in both net sales and order intake,” says Mattias Perjos, President & CEO at Getinge. The medtech company’s net sales increased organically by 0,8% while the order intake rose by 3,9% organically.

07.04.2026
Getinge invites fund managers, analysts, and media to Q1 Report 2026 conference call

Getinge will issue its Q1 Report 2026 on April 21, 2026, at 12.00 p.m. CEST, followed by a conference call at 13:00 p.m. CEST, hosted by Mattias Perjos, President & CEO, and Agneta Palmér, CFO.

26.03.2026
Getinge publishes Annual Report for 2025

Today, Getinge publishes its Annual Report for 2025, including the Sustainability statement. The year was marked by geopolitical friction and significant cost impacts from tariffs and currency movements, while the company delivered strong underlying profitability, continued regulatory progress, and an ambitious innovation agenda.

24.03.2026
Getinge Advances ECLS Technology with Cardiohelp II – The Next Evolution in Extracorporeal Life Support

Getinge today announced the receipt of CE mark for Cardiohelp II, the next evolution of its extracorporeal life support (ECLS) platform. Building on the legacy of Cardiohelp-i - widely recognized within acute care for shaping modern extracorporeal membrane oxygenation (ECMO) transport and extracorporeal life support practice - Cardiohelp II represents the next step forward in intelligent, connected and clinically advanced ECLS.

Пресс-контакт

Caroline Örmgård, Getinge Head of Public & Media Relations

Caroline Örmgård

Head of Public & Media Relations
Tel: +46 10 335 0041

Lars Mattsson, Getinge

Lars Mattsson

Senior Vice President Enterprise Development
Tel: +46 10 335 0043

Katarzyna Sypula,Senior CX Campaigns & Events Manager, Getinge

Katarzyna Sypuła

Senior Customer Experience Campaigns & Events Manager 
CEE/ South Europe / SAPAC
Tel: +48 661 705 706

Newsroom2

Предпочитаете связаться с нами онлайн?

Нажмите ниже, чтобы заполнить соответствующую форму. Мы свяжемся с вами в ближайшее время!

Вы ищете

Getinge Hybrid OR

Галерея

Разнообразный формат изображений доступен для статей в прессе

Man and woman looking a something together

О нас

Все, что вам нужно знать о Getinge одним взглядом

Cardiosave

Срочная коррекция медицинского оборудования

Добровольная срочная полевая коррекция медицинского устройства для внутриаортальной баллонной контрпульсации CARDIOSAVE (IABP)

Newsroom

Не пропустите ничего

Кликайте на иконки и подписывайтесь на нас!